$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

CD36 Repression Activates a Multicellular Stromal Program Shared by High Mammographic Density and Tumor Tissues

Cancer discovery, v.2 no.9, 2012년, pp.826 - 839  

DeFilippis, Rosa Anna (Authors' Affiliations: 1Department of Pathology, 2Comprehensive Cancer Center, 3Department of Medicine and 4Departments of Epidemiology and Biostatistics, University of California San Francisco, San Francisco) ,  Chang, Hang (5Lawrence Berkeley National Laboratory, Berkeley, California) ,  Dumont, Nancy (6Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada) ,  Rabban, Joseph T. (7Department of Patient Centered Research, Division of Breast Oncology, Aurora Health Care, Milwaukee, Wisconsin) ,  Chen, Yunn-Yi (and 8Department of Molecular Cardiology, Lerner Institute, Cleveland Clinic Foundation, Cleveland, Ohio) ,  Fontenay, Gerald V. (Authors' Affiliations: 1Department of Pathology, 2Comprehensive Cancer Center, 3Department of Medicine and 4Departments of Epidemiology and Biostatistics, University of California San Francisco, San Francisco) ,  Berman, Hal K. (5Lawrence Berkeley National Laboratory, Berkeley, California) ,  Gauthier, Mona L. (6Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada) ,  Zhao, Jianxin (7Department of Patient Centered R) ,  Hu, Donglei ,  Marx, James J. ,  Tjoe, Judy A. ,  Ziv, Elad ,  Febbraio, Maria ,  Kerlikowske, Karla ,  Parvin, Bahram ,  Tlsty, Thea D.

Abstract AI-Helper 아이콘AI-Helper

AbstractAlthough high mammographic density is considered one of the strongest risk factors for invasive breast cancer, the genes involved in modulating this clinical feature are unknown. Tissues of high mammographic density share key histologic features with stromal components within malignant lesio...

참고문헌 (50)

  1. Nat Rev Cancer Kalluri 6 392 2006 10.1038/nrc1877 Fibroblasts in cancer 

  2. Semin Cell Dev Biol Arendt 21 11 2010 10.1016/j.semcdb.2009.10.003 Stroma in breast development and disease 

  3. Nat Med Finak 14 518 2008 10.1038/nm1764 Stromal gene expression predicts clinical outcome in breast cancer 

  4. Annu Rev Pathol Tlsty 1 119 2006 10.1146/annurev.pathol.1.110304.100224 Tumor stroma and regulation of cancer development 

  5. Cancer Res Olumi 59 5002 1999 Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium 

  6. Cell Orimo 121 335 2005 10.1016/j.cell.2005.02.034 Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion 

  7. Breast Cancer Res Walker 3 143 2001 10.1186/bcr287 The complexities of breast cancer desmoplasia 

  8. Proc Nutr Soc Bing 68 385 2009 10.1017/S0029665109990267 New insights into adipose tissue atrophy in cancer cachexia 

  9. Cancer Epidemiol Biomarkers Prev Guo 10 243 2001 Growth factors and stromal matrix proteins associated with mammographic densities 

  10. Cancer Epidemiol Biomarkers Prev Li 14 343 2005 10.1158/1055-9965.EPI-04-0490 The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer 

  11. J Natl Cancer Inst Byrne 87 1622 1995 10.1093/jnci/87.21.1622 Mammographic features and breast cancer risk: effects with time, age, and menopause status 

  12. J Natl Cancer Inst Kerlikowske 97 368 2005 10.1093/jnci/dji056 Are breast density and bone mineral density independent risk factors for breast cancer 

  13. J Natl Cancer Inst Boyd 87 670 1995 10.1093/jnci/87.9.670 Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study 

  14. J Natl Cancer Inst Cummings 101 384 2009 10.1093/jnci/djp018 Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk 

  15. Cancer Epidemiol Biomarkers Prev Ziv 13 2090 2004 10.1158/1055-9965.2090.13.12 Mammographic density and estrogen receptor status of breast cancer 

  16. N Engl J Med Boyd 347 886 2002 10.1056/NEJMoa013390 Heritability of mammographic density, a risk factor for breast cancer 

  17. Cancer Epidemiol Biomarkers Prev Ursin 18 102 2009 10.1158/1055-9965.EPI-07-2857 The relative importance of genetics and environment on mammographic density 

  18. J Natl Cancer Inst Chlebowski 95 4 2003 10.1093/jnci/95.1.4 Biological significance of interventions that change breast density 

  19. J Natl Cancer Inst Cuzick 103 744 2011 10.1093/jnci/djr079 Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study 

  20. Cancer Causes Control El-Bastawissi 11 955 2000 10.1023/A:1026514032085 Reproductive and hormonal factors associated with mammographic breast density by age (United States) 

  21. J Natl Cancer Inst Greendale 95 30 2003 10.1093/jnci/95.1.30 Postmenopausal hormone therapy and change in mammographic density 

  22. Breast Cancer Res Haakensen 12 R65 2010 10.1186/bcr2632 Expression levels of uridine 5′-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density 

  23. Breast Cancer Res Treat Yang 119 305 2010 10.1007/s10549-009-0350-0 Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density 

  24. Breast Cancer Res Treat Vachon 125 243 2011 10.1007/s10549-010-0944-6 Aromatase immunoreactivity is increased in mammographically dense regions of the breast 

  25. Sci Signal Silverstein 2 re3 2009 10.1126/scisignal.272re3 CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior 

  26. Bioinformatics Chang 25 1070 2009 10.1093/bioinformatics/btn426 Graphical methods for quantifying macromolecules through bright field imaging 

  27. Physiol Rev Gregoire 78 783 1998 10.1152/physrev.1998.78.3.783 Understanding adipocyte differentiation 

  28. Mol Cell Biochem Sfeir 192 3 1999 10.1023/A:1006811300125 CD36 antisense expression in 3T3-F442A preadipocytes 

  29. J Biol Chem Febbraio 274 19055 1999 10.1074/jbc.274.27.19055 A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism 

  30. J Natl Cancer Inst Yaghjyan 103 1179 2011 10.1093/jnci/djr225 Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics 

  31. Cancer Epidemiol Biomarkers Prev Pereira 20 1718 2011 10.1158/1055-9965.EPI-11-0423 Localized fibroglandular tissue as a predictor of future tumor location within the breast 

  32. Cancer Epidemiol Biomarkers Prev Aiello 14 662 2005 10.1158/1055-9965.EPI-04-0327 Association between mammographic breast density and breast cancer tumor characteristics 

  33. J Clin Oncol Kerlikowske 28 3830 2010 10.1200/JCO.2009.26.4770 Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use 

  34. BMC Genomics Loi 9 239 2008 10.1186/1471-2164-9-239 Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen 

  35. J Clin Oncol Loi 25 1239 2007 10.1200/JCO.2006.07.1522 Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade 

  36. FASEB J Primo 19 1713 2005 10.1096/fj.05-3697fje Identification of CD36 molecular features required for its in vitro angiostatic activity 

  37. Nat Med Jimenez 6 41 2000 10.1038/71517 Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 

  38. Cardiovasc Res Kennedy 89 604 2011 10.1093/cvr/cvq360 A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling 

  39. Semin Cancer Biol Sica 18 349 2008 10.1016/j.semcancer.2008.03.004 Macrophage polarization in tumour progression 

  40. Clin Dev Immunol McDonnell 2010 539519 2010 10.1155/2010/539519 Tumor antigen cross-presentation and the dendritic cell: where it all begins 

  41. Clin Cancer Res Landskroner-Eiger 15 3265 2009 10.1158/1078-0432.CCR-08-2649 Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo 

  42. BMC Med Provenzano 6 11 2008 10.1186/1741-7015-6-11 Collagen density promotes mammary tumor initiation and progression 

  43. Cell Engler 126 677 2006 10.1016/j.cell.2006.06.044 Matrix elasticity directs stem cell lineage specification 

  44. Cell Levental 139 891 2009 10.1016/j.cell.2009.10.027 Matrix crosslinking forces tumor progression by enhancing integrin signaling 

  45. Cardiovasc Res Vinals 66 141 2005 10.1016/j.cardiores.2004.12.024 Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages 

  46. J Leukoc Biol Matasic 66 909 1999 10.1002/jlb.66.6.909 Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells 

  47. Biochem Pharmacol Ruiz-Velasco 67 303 2004 10.1016/j.bcp.2003.09.006 Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-gamma ligands Putative contribution of Rho GTPases in statin-induced CD36 expression 

  48. Arthritis Res Ther Boyer 9 R22 2007 10.1186/ar2133 Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes 

  49. Lancet Saibara 352 404 1998 10.1016/S0140-6736(05)60502-8 Tamoxifen in early breast cancer 

  50. Biostatistics Irizarry 4 249 2003 10.1093/biostatistics/4.2.249 Exploration, normalization, and summaries of high density oligonucleotide array probe level data 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트